WHO Expert Committee on Biological Standardization [meeting held in Geneva from 12 to 18 November 1985] : thirty-sixth report

Announces changes in the status or development of 34 biologicals. The report also presents full details on revised requirements for the manufacturing and national control of tuberculins, dried BCG vaccine, and continuous cell lines, followed by amended requirements for inactivated poliomyelitis vaccine and an addendum to the requirements for antimicrobic susceptibility. A concluding section presents data documenting the history of the production of the WHO primary seed of 17D yellow fever virus to be used in the production of vaccine. As with previous reports from this committee, the present work will serve as both an indispensable reference for manufacturers and control authorities and an integral part of WHOs efforts to assure the production of safe, reliable, and potent biologicals